Access and value solutions
Expertise to maximize value to payers, providers and patients.
There are an increasing number of hurdles on the path to reimbursement and market access for life sciences companies. Today, it is no longer enough to demonstrate efficacy, safety and quality. You need to show economic value — and back it up with powerful data.
At Optum®, we know firsthand what is needed to meet complex coverage and reimbursement requirements. Let us help you get your products to market faster. Our expertise in strategic plan development, health policy assessments and dossier preparation helps us uncover the powerful data needed to tell a persuasive story that demonstrates the efficacy and economic value of your products to all stakeholders. Maximize your opportunities in the marketplace with help from the experts at Optum.
Leveraging tools such as Optum HTA AdvisorTM to understand your target therapeutic markets, we will help you develop a strategy to gather data and gain insights earlier in the development process. Prepared with a plan and the data to support it, you'll have everything you need to demonstrate the value of your products to all stakeholders. You'll be ready to address the coverage and reimbursement requirements of public and private payers and health technology assessment (HTA) agencies.
At a time of growing scrutiny by HTA agencies — accompanied by decreases in government budgets, the initiation of comparative effectiveness and ongoing pressure on brand pricing — the current climate represents a key opportunity for companies to engage in market access research early on in the product development lifecycle. Our extensive health policy expertise in the public and private sectors yields insight into trends and the possible effects of future health policies on your new technologies. We also work closely with our colleagues at The Lewin Group regarding issues of U.S. federal and state health policy, and its potential impact on your portfolio.
Access and value solutions experts
Senior Vice President, Access and Value Solutions, Life Sciences
Vice President, Access and Value Solutions, Life Sciences
Senior Director, Access and Value Solutions, Life Sciences